Announcement

Collapse
No announcement yet.

Pediatr Pulmonol . Clinical features and follow-up of pediatric patients hospitalized for COVID-19

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Pediatr Pulmonol . Clinical features and follow-up of pediatric patients hospitalized for COVID-19


    Pediatr Pulmonol


    . 2021 Apr 14.
    doi: 10.1002/ppul.25407. Online ahead of print.
    Clinical features and follow-up of pediatric patients hospitalized for COVID-19


    Feng Tang 1 , Wanjun Luo 1 , Xiaowen Wang 1 , Hui Li 1 , Hong Mei 1 , Jianbo Shao 1 , Qifa Song 2



    Affiliations

    Abstract

    Objective: This report summarizes the clinical features and 1-month follow-up observations for pediatric patients who were hospitalized with coronavirus disease 2019 (COVID-19) in Wuhan Women and Children's Hospital.
    Methods: The 1-month follow-up data included clinical manifestations and results from serum severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG and IgM tests, reverse-transcription polymerase chain reaction (RT-PCR) for SARS-CoV-2, lung computed tomography (CT) scans, and laboratory tests.
    Results: Between January 20 and March 15, 2020, 127 patients aged 0-15 years were hospitalized for COVID-19 treatment, including 3 severe cases and 124 mild or moderate cases. The main therapies included inhalation of aerosolized interferon-? (122/127) and additional antiviral drugs (28/127). Among the 81 patients who had pneumonia at admission, 35 with right lobe pneumonia had the longest hospital stay (mean 14.5 ? 7 days); 17 with left lobe pneumonia had the highest creatine kinase (154 ? 106 U/L) and creatine kinase myocardial band (CK-MB, 43 ? 48 U/L) levels; and 29 with bilateral pneumonia had the highest white blood cell counts (8.3 ? 4 ? 109 /L). Among the 46 patients who were successfully followed up 1 month after discharge, two notable findings were right lobe pneumonia in 22% (95% confidence interval [CI]: 11%-37%) of patients and persistently elevated serum creatine kinase and CK-MB levels. The median duration of elevated CK-MB was 45 days. The mean concentrations of serum SARS-CoV-2 IgG and IgM in 41 patients were 8.0 ? 7.5 and 98 ? 40 ng/ml, respectively. At follow-up, four patients retested positive for SARS-CoV-2.
    Conclusions: The involvement of different lung lobes in patients with COVID-19 was associated with variations in the persistence of pneumonia and elevation of CK-MB levels and body temperature.

    Keywords: coronavirus disease 2019 (COVID-19); follow-up; pediatric patients; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Working...
X